|
1 |
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Yun-Gyoo Lee, Hyun Chang, Bhumsuk Keam, Sang Hoon Chun, Jihyun Park, Keon Uk Park, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, Keun-Wook Lee, Hye Ryun Kim, Sung-Bae Kim, Myung-Ju Ahn, In Gyu Hwang
Cancer Res Treat.2021;53(3):671-677. Published online 2020 December 7
DOI: http://dx.doi.org/10.4143/crt.2020.824
|
|
2 |
Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi
Obstet Gynecol Sci.2020;63(6):709-718. Published online 2020 September 17
DOI: http://dx.doi.org/10.5468/ogs.20117
|
|
3 |
Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
Dhammapoj Jeerakornpassawat, Prapaporn Suprasert
|
|
4 |
Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
Soo Jin Park, Jihye Kim, Hee Seung Kim, Jeong-Won Lee, Ha Kyun Chang, Keun Ho Lee, Dae-Yeon Kim, Sunghoon Kim, Suk-Joon Chang, Seung Su Han, Sang-Yoon Park, Seung-Hyuk Shim
|
|
5 |
Involved-field radiation therapy for selected cases of recurrent ovarian cancer
Nalee Kim, Jee Suk Chang, Sang Wun Kim, Gun Min Kim, Jung-Yun Lee, Yong Bae Kim
|
|
6 |
Malignant Mixed Mullerian tumors of the ovary: The result of Platinum-based combination chemotherapy following the cytoreductive surgery
Jin Young Ma, Yong Man Kim, Min Hyung Jung, Sang Min Park, Dae Yeon Kim, Jong Hyeok Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok
|
|
7 |
The Response Rate of Carboplatin/Paclitaxel for the Platinum Sensitive Recurrent Ovarian Cancer Patients
Hye Jin Chang, Hee Sug Ryu, Yun Kyoung Lim, Se Hee Moon, Ki Hong Chang, Jung Pil Lee
|
|
8 |
Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
Junghoon Shin, Jin-Haeng Chung, Se Hyun Kim, Kyu Sang Lee, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jeong-Ok Lee, Jin-Won Kim, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee
Cancer Res Treat.2019;51(3):1086-1097. Published online 2018 November 5
DOI: http://dx.doi.org/10.4143/crt.2018.537
|
|
9 |
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
Wonkyo Shin, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
|
|
10 |
Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
Seung Sook Paik, In Kyoung Hwang, Myung Jae Park, Seung Hyeun Lee
|
|
11 |
ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer
Ji-Youn Han, Geon Kook Lee, Kun Young Lim, Young Ju Lee, Byung Ho Nam, Jin Soo Lee
Cancer Res Treat.2017;49(3):678-687. Published online 2016 October 11
DOI: http://dx.doi.org/10.4143/crt.2016.365
|
|
12 |
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Seung Hyeun Lee, Sue In Choi, Ji Sung Lee, Chul Hwan Kim, Won Jai Jung, Eun Joo Lee, Kyung Hoon Min, Gyu Young Hur, Seung Heon Lee, Sung Yong Lee, Je Hyeong Kim, Sang Yeub Lee, Chol Shin, Jae Jeong Shim, Kyung Ho Kang, Kwang Ho In
|
|
13 |
Delay of the Blink Reflex in Patients Receiving Platinum-Analogue Chemotherapy
Kang Young Park, Young Sook Park, Yun Hee Park, Hyun Jung Chang, Eun Sol Cho, Seok-Hyun Kim, Woo Jin Kim
|
|
14 |
Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
Munetaka Takekuma, Shiho Kuji, Aki Tanaka, Nobutaka Takahashi, Masakazu Abe, Yasuyuki Hirashima
|
|
15 |
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations
Sehhoon Park, Bhumsuk Keam, Se Hyun Kim, Ki Hwan Kim, Yu Jung Kim, Jin-Soo Kim, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Jong Seok Lee, Dae Seog Heo
Cancer Res Treat.2015;47(4):630-637. Published online 2015 February 16
DOI: http://dx.doi.org/10.4143/crt.2014.244
|
|
16 |
Characterization and bacterial anti-adherent effect on modified PMMA denture acrylic resin containing platinum nanoparticles
Ki-Young Nam
|
|
17 |
Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis
Ning Zhu, Yi Gong, Jian He, Jingwen Xia, Xiaodong Chen
Yonsei Med J.2013;54(6):1384-1393. Published online 2013 October 1
DOI: http://dx.doi.org/10.3349/ymj.2013.54.6.1384
|
|
18 |
Symptom and Interference of Activities of Daily Living of Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
Jeong Hye Kim, Kyoung Min Lee, Mi Jin Jeon, Mi Ee Seol, Soon Haeng Lee, JeongYun Park
Asian Oncol Nurs.2013;13(3):145-151. Published online 2013 September 30
DOI: http://dx.doi.org/10.5388/aon.2013.13.3.145
|
|
19 |
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
Emma L. Barber, Emese Zsiros, John R. Lurain, Alfred Rademaker, Julian C. Schink, Nikki L. Neubauer
|
|
20 |
Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis
Sang Hoon Chun, Ji Eun Lee, Mi Hee Park, Jin-Hyoung Kang, Young Kyoon Kim, Young-Pil Wang, Jae Kil Park, Hoon-Kyo Kim
|
|